Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trial.
Cheng B, Li C, Li J, Gong L, Liang P, Chen Y, Zhan S, Xiong S, Zhong R, Liang H, Feng Y, Wang R, Wang H, Zheng H, Liu J, Zhou C, Shao W, Qiu Y, Sun J, Xie Z, Liang Z, Yang C, Cai X, Su C, Wang W, He J, Liang W. Cheng B, et al. Signal Transduct Target Ther. 2024 Apr 19;9(1):93. doi: 10.1038/s41392-024-01799-z. Signal Transduct Target Ther. 2024. PMID: 38637495 Free PMC article. Clinical Trial.
Predilection site and risk factor of second primary cancer: A pan-cancer analysis based on the SEER database.
Xiong S, Liang H, Liang P, Cai X, Li C, Zhong R, Li J, Cheng B, Zhu F, Ou L, Chen Z, Zhao Y, Deng H, Chen Z, Liu Z, Xie Z, Li F, He J, Liang W. Xiong S, et al. Among authors: cheng b. Chin Med J (Engl). 2023 Jun 20;136(12):1500-1502. doi: 10.1097/CM9.0000000000002681. Epub 2023 Apr 27. Chin Med J (Engl). 2023. PMID: 37101356 Free PMC article. No abstract available.
Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study.
Deng H, Zhou J, Chen H, Cai X, Zhong R, Li F, Cheng B, Li C, Jia Q, Zhou C, Petersen RH, Rocco G, Brunelli A, Ng CSH, D'Amico TA, Su C, He J, Liang W, Zhu B; AME Thoracic Surgery Collaborative Group. Deng H, et al. Among authors: cheng b. Int J Surg. 2024 Jan 1;110(1):238-252. doi: 10.1097/JS9.0000000000000774. Int J Surg. 2024. PMID: 37755384 Free PMC article.
The impact of PET/CT and brain MRI for metastasis detection among patients with clinical T1-category lung cancer: Findings from a large-scale cohort study.
Feng Y, Cheng B, Zhan S, Liu H, Li J, Chen P, Wang Z, Huang X, Fu X, Ye W, Wang R, Wang Q, Xiang Y, Wang H, Zhu F, Zheng X, Fu W, Hu G, Chen Z, He J, Liang W. Feng Y, et al. Among authors: cheng b. Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3400-3416. doi: 10.1007/s00259-024-06740-8. Epub 2024 May 9. Eur J Nucl Med Mol Imaging. 2024. PMID: 38722381 Free PMC article.
Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma.
Li J, Xiong S, He P, Liang P, Li C, Zhong R, Cai X, Xie Z, Liu J, Cheng B, Chen Z, Liang H, Lao S, Chen Z, Shi J, Li F, Feng Y, Huo Z, Deng H, Yu Z, Wang H, Zhan S, Xiang Y, Wang H, Zheng Y, Lin X, He J, Liang W. Li J, et al. Among authors: cheng b. Neoplasia. 2024 Aug;54:101013. doi: 10.1016/j.neo.2024.101013. Epub 2024 Jun 7. Neoplasia. 2024. PMID: 38850835 Free PMC article.
Landscape of C-MET overexpression in non-small cell lung cancer: a large-scale study of clinicomolecular features and prognosis based on Chinese data.
Zhan S, Li J, Cheng B, Li C, Feng Y, Fan L, Xiong S, Zeng W, Cai Q, Xiang Y, Wang H, Li C, Chen P, Zheng X, Fu W, Hao Z, He J, Liang W. Zhan S, et al. Among authors: cheng b. Ther Adv Med Oncol. 2024 Sep 25;16:17588359241279715. doi: 10.1177/17588359241279715. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39371619 Free PMC article.
5,260 results